Transurethral Resection of Bladder Tumor (TUR-BT) then Concomitant Radiation and Cisplatin Followed by Adjuvant Gemcitabine and Cisplatin in Muscle Invasive Transitional Cell Carcinoma (TCC) of the Urinary Bladder.

Abstract

PURPOSE To evaluate the efficacy, safety, and tolerance of bladder preservation trimodality protocol combining maximal transurethral resection of bladder tumor (TURBT) with concomitant chemoradiation (CCRT) followed by adjuvant chemotherapy in patients with muscle invasive transitional cell carcinoma (TCC) of the bladder. PATIENTS AND METHODS Between… (More)

Topics

Cite this paper

@article{Ibrahim2007TransurethralRO, title={Transurethral Resection of Bladder Tumor (TUR-BT) then Concomitant Radiation and Cisplatin Followed by Adjuvant Gemcitabine and Cisplatin in Muscle Invasive Transitional Cell Carcinoma (TCC) of the Urinary Bladder.}, author={Salwa M. Ibrahim and Zeinab M Abd El-Hafeez and Ehab Mahmoud Mohamed and Iman A Elsharawy and Khaled M Kamal}, journal={Journal of the Egyptian National Cancer Institute}, year={2007}, volume={19 1}, pages={77-86} }